Prevalence and Factors Associated with Hypertension Among HIV Positive Patients on Antiretroviral Therapy: A Hospital-Based Cross-Sectional Study in Rwanda

References

• Bello SI, Ojieabu WA. Hypertension and related risk factors among clients on combined antiretroviral therapy in Nigeria. J Pharm Pharma Sci. 2017;9(4):4–10. doi10.21065/1920-4159.1000252
   Google Scholar
• World Health Organization (WHO). HIV/AIDS Fact Sheet; 2021. Available from: http://www.who.int/news-room/fact-sheets/detail/hiv-aids. Accessed November 23, 2022.
   Google Scholar
• Seidu A-A, Opoku Ahinkorah B, Louis Kobina Dadzie JKT, et al. A multi-country cross-sectional study of self-reported sexually transmitted infections among sexually active men in sub-Saharan Africa. BMC Public Health. 2020;20:1884. doi:10.1186/s12889-020-09996-5
   PubMed Web of Science ®Google Scholar
• Rücker SCM, Tayea A, Bitilinyu-Bangoh J, et al. High rates of hypertension, diabetes, elevated low-density lipoprotein cholesterol, and cardiovascular disease risk factors in HIV-infected patients in Malawi. Aids. 2018;32(2):253–260. doi:10.1097/QAD.0000000000001700
   PubMed Web of Science ®Google Scholar
• Lubega G, Mayanja B, Lutaakome J, Abaasa A, Thomson R, Lindan C. Prevalence and factors associated with hypertension among people living with HIV/AIDS on antiretroviral therapy in Uganda. Pan Afr Med J. 2021;38. doi:10.11604/pamj.2021.38.216.28034
   Google Scholar
• Diouf A, Cournil A, Ba-Fall K, et al. Diabetes and hypertension among patients receiving antiretroviral treatment since 1998 in senegal: prevalence and associated factors. Isrn Aids. 2012;2012:1–8. doi:10.5402/2012/621565
   Google Scholar
• Harimenshi D, Niyongabo T, Preux PM, Aboyans V, Desormais I. Hypertension and associated factors in HIV-infected patients receiving antiretroviral treatment in Burundi: a cross-sectional study. Sci Rep. 2022;12(1):1–8. doi:10.1038/s41598-022-24997-7
   PubMed Web of Science ®Google Scholar
• Abbafati C, Abbas KM, Abbasi-Kangevari M, et al. Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the global burden of disease study 2019. Lancet. 2020;396(10258):1223–1249. doi:10.1016/S0140-6736(20)30752-2
   PubMed Web of Science ®Google Scholar
• Badacho AS, Mahomed OH. Prevalence of hypertension and diabetes and associated risk factors among people living with human immunodeficiency virus in Southern Ethiopia. Front Cardiovasc. 2023;10:1173440. doi:10.3389/fcvm.2023.1173440
   PubMed Web of Science ®Google Scholar
• World Health Organization. Estimated Number of People (All Ages) Living with HIV; 2022. Available from: https://www.who.int/data/gho/data/indicators/indicator-details/GHO/estimated-number-of-people--living-with-hiv#:~:text=SituationandtrendsIn2022,–31.2million%5Din. Accessed December 22, 2023.
   Google Scholar
• Yunan X. A Global Prevalence of Hypertension Among People Living with HIV: A Systematic Review. Univ Florida, Gainesv; 2017.
   Google Scholar
• Assefa Y, Gilks CF. Ending the epidemic of HIV/AIDS by 2030: will there be an endgame to HIV, or an endemic HIV requiring an integrated health systems response in many countries? Lancet. 2022;100:273–277. doi:10.1016/j.ijid.2020.09.011
   Google Scholar
• Nduka C, Stranges S, Sarki AM, et al. Evidence of increased blood pressure and hypertension risk among people living with HIV on antiretroviral therapy: a systematic review with meta-analysis. J Hum Hypertens. 2015;30(6):355–362. doi:10.1038/jhh.2015.97
   PubMed Web of Science ®Google Scholar
• Manavalan P, Madut DB, Hertz JT, et al. Hypertension burden and challenges across the hypertension treatment cascade among adults enrolled in HIV care in northern Tanzania. J Clin Hypertens. 2020;22(8):1518–1522. doi:10.1111/jch.13929
   Web of Science ®Google Scholar
• Nahimana M-R, Nyandwi A, Muhimpundu MA, et al. A population-based national estimate of the prevalence and risk factors associated with hypertension in Rwanda: implications for prevention and control. BMC Public Health. 2018;18(2):1–11. doi:10.1186/s12889-017-4536-9
   Google Scholar
• Sander L, Newell K, Ssebbowa P, et al. Hypertension, cardiovascular risk factors and antihypertensive medication utilisation among HIV-infected individuals in Rakai, Uganda; 2015:20.
   Google Scholar
• Van Zoest RA, Van Den Born BJH, Reiss P. Hypertension in people living with HIV. Curr Opin HIV AIDS. 2017;12(6):513–522. doi:10.1097/COH.0000000000000406
   PubMed Web of Science ®Google Scholar
• Cosimo M. Lifestyle and hypertension: an evidence-based review. J Hypertens Manag. 2018;4:1.
   Google Scholar
• Yao L, Lu M, Dai H, et al. Lifestyle and risk of hypertension: follow-up of a young pre-hypertensive cohort. Int J Med Sci. 2015;12(7):605–612. doi:10.7150/ijms.12446
   PubMed Web of Science ®Google Scholar
• Akinlua JT, Meakin R, Umar AM, Freemantle N, Reboldi G. Current prevalence pattern of hypertension in Nigeria: a systematic review. PLoS One. 2015;10(10):1–18. doi:10.1371/journal.pone.0140021
   Web of Science ®Google Scholar
• Odukoya O, Badejo O, Sodeinde K, Olubodun T. Behavioral risk factors for hypertension among adults living with HIV accessing care in secondary health facilities in Lagos State, Nigeria. J Fam Med Prim Care. 2017;6(2):169–170.
   PubMedGoogle Scholar
• Tsuro U, Oladimeji KE, Pulido-Estrada GA, Apalata TR. Risk factors attributable to hypertension among HIV-infected patients on antiretroviral therapy in selected rural districts of the Eastern Cape Province, South Africa. Int J Environ Res Public Health. 2022;19(18):11196. doi:10.3390/ijerph191811196
   PubMed Web of Science ®Google Scholar
• Nguyen KA, Peer N, Mills EJ, Kengne AP. Burden, determinants, and pharmacological management of hypertension in HIV-positive patients and populations: a systematic narrative review. AIDS Rev. 2015;17(2):83–95.
   PubMed Web of Science ®Google Scholar
• Musekwa R, Hamooya BM, Koethe JR, Nzala S, Masenga SK. Prevalence and correlates of hypertension in HIV-positive adults from the Livingstone Central Hospital, Zambia. Pan Afr Med J. 2021;39. doi:10.11604/pamj.2021.39.237.29718
   Web of Science ®Google Scholar
• Perin J, Mulick A, Yeung D, et al. Global, regional, and national causes of under-5 mortality in 2000–19: an updated systematic analysis with implications for the Sustainable Development Goals. Lancet Child Adolesc Heal. 2022;6(2):106–115. doi:10.1016/S2352-4642(21)00311-4
   Web of Science ®Google Scholar
• Semeere AS. Hypertension and associated risk factors in individuals infected with HIV on antiretroviral therapy at an urban HIV clinic in Uganda. Lancet Glob Heal. 2014;2. doi:10.1016/S2214-109X(15)70045-8
   Google Scholar
• Rodríguez-Arbolí E, Mwamelo K, Kalinjuma AV, et al. Incidence and risk factors for hypertension among HIV patients in rural Tanzania – a prospective cohort study. PloS one. 2017:630. doi:10.1371/journal.pone.0172089
   Google Scholar
• IFPMA. HYPERTENSION: putting the Pressure on the silent Killer; May; 2016.
   Google Scholar
• MoH. Rwanda Non communicable: risk, Factors Diseases Report. 2015.
   Google Scholar
• Davis K, Perez-Guzman P, Hoyer A, et al. Association between HIV infection and hypertension: a global systematic review and meta-analysis of cross-sectional studies. BMC Med. 2021;19(1). doi:10.1186/s12916-021-02112-3
   Web of Science ®Google Scholar
• Isaac Derick K, Khan Z. Prevalence, Awareness, Treatment, Control of Hypertension, and Availability of Hypertension Services for Patients Living With Human Immunodeficiency Virus (HIV) in Sub-Saharan Africa (SSA): a Systematic Review and Meta-analysis. Cureus. 2023;15(4):1–16. doi:10.7759/cureus.37422
   Web of Science ®Google Scholar
• Okello S, Muhihi A, Mohamed SF, et al. Hypertension prevalence, awareness, treatment, and control and predicted 10-year CVD risk: a cross-sectional study of seven communities in East and West Africa (SevenCEWA). BMC Public Health. 2020;20(1):1–13. doi:10.1186/s12889-020-09829-5
   PubMed Web of Science ®Google Scholar
• Bayaraa N, Azahar NM, Kitaoka K, Kobayashi Y, Yano Y. African Control of Hypertension through Innovative Epidemiology and a Vibrant Ecosystem (ACHIEVE): a holistic approach for hypertension control in Africa. J Hum Hypertens. 2023. doi:10.1038/s41371-023-00845-7
   PubMed Web of Science ®Google Scholar
• Cochran WG. Sampling Techniques. Vol. 3. 3rd. john wiley \& sons; 2004 doi:10.1038/hr.2011.133
   Google Scholar
• Williams B, Mancia G, Spiering W, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018;39(33):3021–3104. doi:10.1097/HJH.0000000000001940
   PubMed Web of Science ®Google Scholar
• ESIOBU E. The rise of homegrown ideas and grassroots voices: new directions in social policy in Rwanda; 2017. Available from: www.econstor.eu. Accessed December 22, 2023.
   Google Scholar
• Nshutinzima AJ, Biracyaza E, Muhayisa A, Mukarusanga I, Mutabaruka J. Family determinants of substance use among Rwandan youths: a case study of Gitagata Rehabilitation Centre. J Subst Use. 2023;1–9. doi:10.1080/14659891.2023.2284945
   Web of Science ®Google Scholar
• Murwanashyaka J de D, Ndagijimana A, Biracyaza E, Sunday FX, Umugwaneza M. Non-adherence to medication and associated factors among type 2 diabetes patients at clinique medicale fraternite, Rwanda: a cross-sectional study. BMC Endocr Disord. 2022;22(1):1–14. doi:10.1186/s12902-022-01133-0
   PubMed Web of Science ®Google Scholar
• Lukas K, Markos E, Belayneh F, Habte A, Torpey K. The magnitude of hypertension and associated factors among clients on highly active antiretroviral treatment in Southern Ethiopia, 2020: a hospital-based cross-sectional study. PlosOne. 2021;10(6):e0258576. doi:10.1371/journal.pone.0258576
   Google Scholar
• Saito A, Karama M, Kamiya Y. HIV infection, and overweight and hypertension: a cross-sectional study of HIV-infected adults in Western Kenya. Trop Med Health. 2020;48(1). doi:10.1186/s41182-020-00215-w
   Web of Science ®Google Scholar
• Gebrie A, Gebremedhin S. Hypertension among people living with human immunodeficiency virus receiving care at referral hospitals of Northwest Ethiopia: a cross-sectional study. PLoS One. 2020;15(8):1–13. doi:10.1371/journal.pone.0238114
   Web of Science ®Google Scholar
• Badru O, Oduola T, Abdulrazaq A, Peter C. Prevalence and predictive factors of hypertension among people living with HIV in Kebbi State, Nigeria: a cross-sectional study. J Assoc Nurses AIDS Care. 2020;33(1):e6–e14. doi:10.1097/JNC.0000000000000309
   Web of Science ®Google Scholar
• Mulugeta H, Afenigus AD, Haile D, et al. Incidence and predictors of hypertension among HIV patients receiving art at public health facilities, northwest Ethiopia: a one-year multicenter prospective follow-up study. HIV/AIDS - Res Palliat Care. 2021;13:889–901. doi:10.2147/HIV.S329838
   Web of Science ®Google Scholar
• Sewale Y, Afenigus AD, Haile D, Shiferaw WS. Magnitude of hypertension and associated factors among human immunodeficiency virus positive adults receiving anti-retroviral therapy at Debre Markos referral hospital, northwest, Ethiopia. HIV/AIDS - Res Palliat Care. 2020;12:629–637. doi:10.2147/HIV.S280630
   Google Scholar
• Mbuthia GW, Magutah K, Mcgarvey ST. The Prevalence and Associated Factors of Hypertension among HIV Patients. Int J Hypertens. 2021;15:5544916. doi:10.1155/2021/5544916
   Google Scholar
• Anwer Z. Hypertension management in diabetic patients. Eur Rev Med Pharmacol Sci. 2011;15:1.
   PubMed Web of Science ®Google Scholar
• Njeru JIW. Prevalence and associated risk factors for hypertension among HIV positive patients attending comprehensive care centre at Thika District hospital, Kenya, 2008 James Ian Wathuta Njeru A Thesis Submitted in Partial Fulfillment for the Degree of Master of; 2009.
   Google Scholar
• Mbuthia GW, Magutah K, Mcgarvey ST, Moreira TMM. The prevalence and associated factors of hypertension among HIV patients. Int J Hypertens. 2021;2021:1–8. doi:10.1155/2021/5544916
   Google Scholar
• Fiseha T, Belete AG, Dereje H, Dires A. Hypertension in HIV-infected patients receiving antiretroviral therapy in Northeast Ethiopia. Int J Hypertens. 2019;2019:1–7. doi:10.1155/2019/4103604
   Web of Science ®Google Scholar
• Jacques B, Joliana P. Prevalence of hypertension among working adults in Rwanda. Iran J Publ Heal. 2013;42(8).
   Web of Science ®Google Scholar
• Olin BR. Hypertension: the Silent Killer: updated JNC-8 Guideline Recommendations; 2018.
   Google Scholar
• CADTH. Peer support for diabetes, heart disease and HIV/AIDS: a Review of the clinical effectiveness, cost-effectiveness, and guidelines. PubMed. 2013.
   Google Scholar
• Zewudie BT, Geze Tenaw S, Solomon M, et al. The magnitude of undiagnosed hypertension and associated factors among HIV-positive patients attending antiretroviral therapy clinics of Butajira General Hospital, Gurage Zone, Southern Ethiopia. SAGE Open Med. 2022;10:1–7. doi:10.1177/20503121221094454
   Web of Science ®Google Scholar
• Dzudie A, Hoover D, Kim HY, et al. Hypertension among people living with HIV/ AIDS in Cameroon: a cross-sectional analysis from Central Africa International Epidemiology Databases to Evaluate AIDS. PLoS One. 2021;16(7):1–17. doi:10.1371/journal.pone.0253742
   Web of Science ®Google Scholar
• Dechasa M, Nigussie S, Jambo A, et al. The magnitude of hypertension and its contributing factors among patients receiving antiretroviral therapy in public hospitals in Harar City, Eastern Ethiopia: A Cross-Sectional Study. Integr Blood Press Control. 2023;16:81–93. doi:10.2147/ibpc.s433907
   PubMed Web of Science ®Google Scholar
• Lukas K, Markos E, Belayneh F, Habte A, Torpey K. The magnitude of hypertension and associated factors among clients on highly active antiretroviral treatment in Southern Ethiopia, 2020: a hospital-based cross-sectional study. PLoS One. 2021;16(10):1–15. doi:10.1371/journal.pone.0258576
   Web of Science ®Google Scholar